Chiaki Kamei Selected Research

zafirlukast (Accolate)

11/2007	Participation in cysteinyl leukotrienes and thromboxane A2 in nasal congestion model in Brown Norway rats.
11/2004	Participation of chemical mediators in the development of experimental allergic conjunctivitis in rats.
1/2004	A chronic model for evaluating the itching associated with allergic conjunctivitis in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chiaki Kamei Research Topics

Disease

16	Seizures (Absence Seizure) 01/2021 - 11/2003
16	Sneezing 10/2013 - 05/2002
11	Allergic Rhinitis 06/2009 - 02/2002
10	Memory Disorders (Memory Loss) 01/2021 - 04/2003
6	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 04/2010 - 04/2002
6	Pruritus (Itching) 03/2010 - 01/2004
6	Atopic Dermatitis (Atopic Eczema) 01/2010 - 07/2005
6	Hypersensitivity (Allergy) 03/2008 - 05/2002
4	Edema (Dropsy) 01/2009 - 04/2003
3	Sleepiness 01/2010 - 02/2009
3	Sleep Initiation and Maintenance Disorders (Insomnia) 11/2008 - 04/2004
2	Dementia (Dementias) 01/2010 - 11/2009
2	Anaphylaxis (Anaphylactic Shock) 03/2008 - 09/2007
1	Central Nervous System Diseases (CNS Diseases) 11/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Complex Partial Epilepsy (Psychomotor Epilepsy) 03/2010
1	Generalized Epilepsy 03/2010
1	Skin Diseases (Skin Disease) 03/2010
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2010
1	Sleep Deprivation 01/2010

Drug/Important Bio-Agent (IBA)

24	Histamine (Histamine Dihydrochloride)FDA Link 01/2021 - 04/2002
10	AntigensIBA 01/2009 - 02/2002
6	Anticonvulsants (Antiepileptic Drugs)IBA 03/2010 - 12/2006
6	Pharmaceutical PreparationsIBA 01/2010 - 03/2004
6	p-Methoxy-N-methylphenethylamineIBA 01/2009 - 01/2006
5	Hypnotics and Sedatives (Sedatives)IBA 01/2021 - 04/2004
4	Cetirizine (Zyrtec)FDA LinkGeneric 10/2013 - 11/2003
4	Carbamazepine (Tegretol)FDA LinkGeneric 03/2010 - 05/2007
4	Pyrilamine (Mepyramine)FDA Link 01/2010 - 11/2003
4	Donepezil (Aricept)FDA LinkGeneric 11/2009 - 01/2007
4	Scopolamine (Hyoscine)FDA Link 10/2009 - 12/2007
3	thioperamideIBA 01/2021 - 03/2004
3	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2011 - 01/2010
3	AcidsIBA 01/2011 - 01/2010
3	Valproic Acid (Depakote)FDA LinkGeneric 03/2010 - 08/2008
3	Immunoglobulin E (IgE)IBA 06/2009 - 07/2007
3	Cholinergic Agents (Cholinergics)IBA 11/2008 - 11/2006
3	OvalbuminIBA 11/2007 - 04/2002
3	zafirlukast (Accolate)FDA LinkGeneric 11/2007 - 01/2004
3	Histamine H1 Receptors (Histamine H1 Receptor)IBA 11/2006 - 05/2002
2	Clobazam (HR 376)IBA 03/2010 - 04/2009
2	Topiramate (Topamax)FDA LinkGeneric 03/2010 - 05/2007
2	Zonisamide (Zonegran)FDA LinkGeneric 03/2010 - 04/2009
2	Morphine (MS Contin)FDA LinkGeneric 02/2010 - 11/2009
2	Memantine (Namenda)FDA Link 01/2010 - 11/2009
2	Methylphenidate (Ritalin)FDA LinkGeneric 01/2010 - 11/2009
2	NNC 711 (NO 711)IBA 01/2010 - 04/2009
2	GABA-C receptor (receptor, GABA(C))IBA 01/2010 - 04/2009
2	Diazepam (Valium)FDA LinkGeneric 01/2010 - 08/2008
2	gamma-Aminobutyric Acid (GABA)IBA 01/2010 - 04/2009
2	GlucocorticoidsIBA 01/2010 - 01/2009
2	Histamine H1 AntagonistsIBA 01/2010 - 01/2010
2	BenzodiazepinesIBA 09/2009 - 11/2008
2	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 06/2009 - 04/2009
2	levocabastine (Bilina)FDA Link 04/2009 - 03/2005
2	Ethosuximide (Zarontin)FDA LinkGeneric 04/2009 - 08/2008
2	TeicoplaninIBA 04/2009 - 08/2008
2	Propolis (Bee Bread)IBA 01/2009 - 04/2003
2	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2009 - 11/2005
2	tandospironeIBA 11/2008 - 09/2007
2	MecamylamineIBA 11/2008 - 12/2007
2	Histamine H3 Receptors (Histamine H3 Receptor)IBA 10/2008 - 08/2008
2	TachykininsIBA 08/2008 - 07/2007
2	clobenpropitIBA 08/2008 - 03/2004
2	Amitriptyline (Elavil)FDA LinkGeneric 07/2008 - 03/2007
2	ThromboxanesIBA 11/2007 - 04/2003
2	ramatrobanIBA 11/2007 - 11/2004
2	cysteinyl-leukotrieneIBA 11/2007 - 01/2004
2	SolutionsIBA 08/2007 - 05/2002
2	Substance PIBA 07/2007 - 02/2006
2	salicylhydroxamic acid (SHAM)IBA 03/2007 - 11/2003
2	Imipramine (Janimine)FDA LinkGeneric 03/2007 - 11/2006
2	Histidine (L-Histidine)FDA Link 11/2006 - 04/2004
2	Loratadine (Alavert)FDA Link 07/2005 - 11/2003
1	2-methylhistamineIBA 01/2021
1	sigma-2 receptorIBA 11/2019
1	AcetylcholinesteraseIBA 01/2018
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2018
1	ButyrylcholinesteraseIBA 01/2018
1	Cholinesterases (Cholinesterase)IBA 01/2018
1	levocetirizine FDA LinkGeneric 10/2013
1	metabotropic glutamate receptor 2IBA 01/2011
1	2-amino-4-phosphono-propinateIBA 01/2011
1	metabotropic glutamate receptor type 1IBA 01/2011
1	metabotropic glutamate receptor 4IBA 01/2011
1	Environmental Pollutants (Pollutants, Environmental)IBA 03/2010
1	Polychlorinated Dibenzodioxins (TCDD)IBA 03/2010
1	Opioid Receptors (Opioid Receptor)IBA 02/2010
1	Opioid Analgesics (Opioids)IBA 02/2010
1	Fentanyl (Sublimaze)FDA LinkGeneric 02/2010
1	GABA-A Receptor AntagonistsIBA 01/2010
1	3,4-dihydroxyphenylglycolIBA 01/2010
1	Prednisolone (Predate)FDA LinkGeneric 01/2010
1	BicucullineIBA 01/2010
1	sulprostoneIBA 01/2010
1	Olopatadine Hydrochloride (Patanol)FDA Link 01/2010
1	Toluene 2,4-Diisocyanate (Toluene Diisocyanate)IBA 01/2010

Therapy/Procedure

6	Intraperitoneal Injections 01/2021 - 11/2003
3	Oral Administration 04/2009 - 12/2006
1	Intradermal Injections 02/2010